Home>Publications>Trends in Medicaid-Reimbursed Outpatient Buprenorphine, Naltrexone, and Naloxone Prescriptions following New Jersey P.L. 2017, c.28 Trends in Medicaid-Reimbursed Outpatient Buprenorphine, Naltrexone, and Naloxone Prescriptions following New Jersey P.L. 2017, c.28 Manisha Agrawal, Kristen Lloyd, Joel C. Cantor, Jennifer Farnham, Margaret Koller Focus Area: Population Health Type: Issue Briefs Book Title: Editor Name: Publisher: Rutgers Center for State Health PolicyNew Brunswick, NJ Meeting Title: Journal Title: Publisher URL: Volume: Issue: Pages: Place of Meeting: Date: October 2019 Keywords: New Jersey Public Law 2017, c.28, Medication-Assisted Treatment (MAT), Medicaid-Reimbursed, Buprenorphine Download Publication More Publications on Population Health Disparate Cardiovascular Hospitalization Trends Among Young and Middle‐Aged Adults Within and Across Race and Ethnicity Groups in Four States in the United States The Impact of Payment Reforms on the Safety Net: Examining Effects of the New Jersey Delivery System Reform Incentive Payment Program on Quality of Care among Medicaid Beneficiaries Broadening the Lens: The Importance of Addressing Health-Related Social Needs in Clinical Settings Trends in Cancer Screening among Medicaid Enrollees in New Jersey: 2011–2017 Evidence That Changes in Community Food Environments Lead to Changes in Children's Weight: Results from a Longitudinal Prospective Cohort Study More +